Net cash company, success to win the Singapore market as huge growth in Singapore revenue. In future, they success to be the PARTNERS WITH BLOKHIN – THE LARGEST CANCER RESEARCH CENTER IN EUROPE which will further increase the revenue in future. Huat ar...
UCREST: Q4 RECORD HIGH, FY2018 REVENUE SOARS 745%, RECORD PROFIT FOR THE YEAR
(30 July 2018, Kuala Lumpur) UCrest Berhad (formerly Palette Multimedia Berhad) has announced its Q4 FY2018 financial result today that it has achieved another record high quarter. The Company has been achieving record high in the past 5 consecutive quarters in revenues and profits.
The Company achieved revenue of RM16.9M of and a profit of slightly above RM4.0M for the quarter ending May 31, 2018, which is 37% increase in revenue and 15% increase in profit over Q3 FY2018.
The revenue for FY2018 soars to RM48.3M as compared to RM5.7M in FY2017, a steep increase of 745%. The Company achieved record high profit of RM14.2M for FY2018 as compared to a loss of RM0.8M in FY2017.
According the market report, the global market for mobile health in 2017 is USD23B with CAGR of 35% over the next few years.
“The strong financial result is due to increasingly more doctors and hospitals embracing our technologies led by the innovative hospitals and doctors who are more tech-savvy. They are the ones that will power up the disruption in the medical practices using the latest and most advance technologies for diagnosis and therapeutic to achieve a higher success rate for the benefits of the patients,” commented Mr. Eg Kah Yee, Chairman of UCrest. “Market reports show that the online and AI medicines market is growing rapidly as seen parallelly in our financial result. We expect this trend to continue over the next few years,” he added.
The Company’s imedic™ enables doctors anywhere in the world to provide online medical services to patients, giving patients the best available medical services. Based on the block chain technology, imedic™ is protecting the patient medical records with the ultimate security.
Patients using imedic™ managed by doctors regularly have prevented fatal heart attack or managed to save their own life.
Nice. Great news. One of jewel in Bursa...its business concept work on a really high profit margin i guess, its earning easily to sky rocket in the future upon new business deal.
Hope the earning would be the catalyst for the stocks to rally in the near term. It had to because next target for uptrend target should be 57cent. If not will look to buy more for bargain. Trade base on your research.
For me, just hantam, go long term. Will see ur investment skyrocket too.
Future business prospects and earnings growth is more important than the current results....looking forward to much better times....this is where the action is and will be reflected in the share price....going forward. But don't expect it to move in a straight line....punters can still pick up some crumbs along the way.....they can't get the loaves, though.....these are reserved for the patient and faithful investors. You get what you deserve...the choice is yours.
IMedic Business is the business that may explode and growth can be exponential once the ground work completed and confident is there. Profit margin would improve further with sales too.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Hedge Fund
214 posts
Posted by Hedge Fund > 2018-07-30 09:07 | Report Abuse
bought 1m last week